DK1084261T3 - Rekombinant vaccine mod venezuelansk hesteencephalitis - Google Patents

Rekombinant vaccine mod venezuelansk hesteencephalitis

Info

Publication number
DK1084261T3
DK1084261T3 DK99920967T DK99920967T DK1084261T3 DK 1084261 T3 DK1084261 T3 DK 1084261T3 DK 99920967 T DK99920967 T DK 99920967T DK 99920967 T DK99920967 T DK 99920967T DK 1084261 T3 DK1084261 T3 DK 1084261T3
Authority
DK
Denmark
Prior art keywords
vaccine against
equine encephalitis
venezuelan equine
recombinant vaccine
against venezuelan
Prior art date
Application number
DK99920967T
Other languages
Danish (da)
English (en)
Inventor
Alice Marie Bennett
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of DK1084261T3 publication Critical patent/DK1084261T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99920967T 1998-05-29 1999-05-05 Rekombinant vaccine mod venezuelansk hesteencephalitis DK1084261T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9811433A GB2337755B (en) 1998-05-29 1998-05-29 Virus vaccine
EP99920967A EP1084261B8 (en) 1998-05-29 1999-05-05 Recombinant venezuelan equine encephalitis virus vaccine

Publications (1)

Publication Number Publication Date
DK1084261T3 true DK1084261T3 (da) 2005-01-17

Family

ID=10832820

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99920967T DK1084261T3 (da) 1998-05-29 1999-05-05 Rekombinant vaccine mod venezuelansk hesteencephalitis

Country Status (14)

Country Link
US (2) US6936257B1 (pt)
EP (1) EP1084261B8 (pt)
AR (1) AR020080A1 (pt)
AT (1) ATE275631T1 (pt)
AU (1) AU3834999A (pt)
BR (1) BR9910814A (pt)
CA (1) CA2329133C (pt)
DE (1) DE69920011T2 (pt)
DK (1) DK1084261T3 (pt)
ES (1) ES2224655T3 (pt)
GB (1) GB2337755B (pt)
MX (1) MXPA00011708A (pt)
PT (1) PT1084261E (pt)
WO (1) WO1999063098A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2337755B (en) 1998-05-29 2003-10-29 Secr Defence Virus vaccine
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
US20020106798A1 (en) 2000-03-02 2002-08-08 Robinson Harriet L. DNA expression vectors and methods of use
CA2454959C (en) 2001-03-08 2018-07-10 Bernard Moss Mva expressing modified hiv envelope, gag, and pol genes
EP1528677B1 (en) * 2003-10-30 2006-05-10 Agilent Technologies, Inc. Film acoustically-coupled transformer with two reverse c-axis piezoelectric elements
WO2008101349A1 (en) * 2007-02-23 2008-08-28 Her Majesty The Queen, In Right Of Canada, As Repesented By The Minister Of National Defence Recombinant viral vectors for prevention and protection against alphavirus infection
EP2440251A4 (en) * 2009-06-09 2013-01-16 Defyrus Inc INTERFERON ADMINISTRATION FOR PROPHYLAXIS AGAINST PATHOGEN INFECTION OR TREATMENT OF PATHOGEN INFECTION
AU2012217723A1 (en) 2011-02-15 2013-08-29 Immune Design Corp. Methods for enhancing immunogen specific immune responses by vectored vaccines
SG194083A1 (en) 2011-04-08 2013-11-29 Immune Design Corp Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
US9555090B2 (en) 2012-04-04 2017-01-31 The United States of America as repesented by the Secretary of Army, on behalf of the U.S. Army Medical Research Institute of Infections Diseases Equine encephalitis virus vaccines and methods of using thereof
WO2013173590A1 (en) 2012-05-16 2013-11-21 Immune Design Corp. Vaccines for hsv-2
DK3556206T3 (da) * 2012-11-05 2021-08-09 Regeneron Pharma Genmodificerede ikke-humane dyr og fremgangsmåder til anvendelse deraf
JP6581101B2 (ja) 2014-02-14 2019-09-25 イミューン デザイン コーポレイション 局所免疫刺激及び全身免疫刺激の組み合わせによる癌の免疫療法
AU2015289773A1 (en) 2014-07-15 2017-02-02 Immune Design Corp. Prime-boost regimens with a TLR4 agonist adjuvant and a lentiviral vector
EP3407910B1 (en) 2016-01-29 2022-04-13 Bavarian Nordic A/S Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine
SG11201808783XA (en) 2016-04-15 2018-11-29 Alpine Immune Sciences Inc Cd80 variant immunomodulatory proteins and uses thereof
JP7058609B2 (ja) 2016-04-15 2022-04-22 アルパイン イミューン サイエンシズ インコーポレイテッド Ｉｃｏｓリガンドバリアント免疫調節タンパク質およびその使用
WO2018022946A1 (en) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Cd155 variant immunomodulatory proteins and uses thereof
WO2018022945A1 (en) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Cd112 variant immunomodulatory proteins and uses thereof
US11471488B2 (en) 2016-07-28 2022-10-18 Alpine Immune Sciences, Inc. CD155 variant immunomodulatory proteins and uses thereof
PT3596116T (pt) 2017-03-16 2023-12-04 Alpine Immune Sciences Inc Proteínas imunomoduladoras de pd-l1 variante e suas utilizações
AU2018235838B2 (en) 2017-03-16 2023-12-14 Alpine Immune Sciences, Inc. CD80 variant immunomodulatory proteins and uses thereof
CA3053812A1 (en) 2017-03-16 2018-09-20 Alpine Immune Sciences, Inc. Pd-l2 variant immunomodulatory proteins and uses thereof
KR20190135017A (ko) 2017-03-30 2019-12-05 더 유니버서티 어브 퀸슬랜드 키메라 분자 및 그의 용도
US20210196792A1 (en) 2017-09-01 2021-07-01 The Australian National University Immunoregulatory molecules and uses therefor
MA50360A (fr) 2017-10-10 2020-08-19 Alpine Immune Sciences Inc Protéines immunomodulatrices de variants de ctla-4 et leurs utilisations
MA50404A (fr) 2017-10-18 2020-08-26 Alpine Immune Sciences Inc Protéines immunomodulatrices à variants de ligand de icos variant, compositions et méthodes associées
CA3087149A1 (en) 2018-01-03 2019-07-11 Alpine Immune Sciences, Inc. Multi-domain immunomodulatory proteins and methods of use thereof
WO2019241758A1 (en) 2018-06-15 2019-12-19 Alpine Immune Sciences, Inc. Pd-1 variant immunomodulatory proteins and uses thereof
MA53651A (fr) 2018-09-19 2021-07-28 Alpine Immune Sciences Inc Méthodes et utilisations de protéines de fusion de variant cd80 et constructions associées
AU2019389151A1 (en) 2018-11-30 2021-06-10 Alpine Immune Sciences, Inc. CD86 variant immunomodulatory proteins and uses thereof
MX2021012607A (es) 2019-04-17 2022-03-11 Alpine Immune Sciences Inc Metodos y usos de proteinas de fusion de ligando icos (icosl) variante.
IL297980A (en) 2020-05-08 2023-01-01 Alpine Immune Sciences Inc Immunomodulatory proteins that inhibit april and baff and methods of using them
EP4333869A1 (en) 2021-05-07 2024-03-13 Alpine Immune Sciences, Inc. Methods of dosing and treatment with a taci-fc fusion immunomodulatory protein
WO2023172883A1 (en) 2022-03-07 2023-09-14 Alpine Immune Sciences, Inc. Immunomodulatory proteins of variant cd80 polypeptides, cell therapies thereof and related methods and uses
WO2024077018A2 (en) 2022-10-04 2024-04-11 Alpine Immune Sciences, Inc. Methods and uses of taci-fc fusion immunomodulatory protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185440A (en) * 1989-06-20 1993-02-09 North Carolina State University cDNA clone coding for Venezuelan equine encephalitis virus and attenuating mutations thereof
US5505947A (en) * 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
US6261570B1 (en) * 1997-05-20 2001-07-17 The United States Of America As Represented By The Secretary Of The Army Live attenuated virus vaccines for western equine encephalitis virus, eastern equine encephalitis virus, and venezuelan equine encephalitis virus IE and IIIA variants
GB2337755B (en) 1998-05-29 2003-10-29 Secr Defence Virus vaccine

Also Published As

Publication number Publication date
GB9811433D0 (en) 1998-07-22
MXPA00011708A (es) 2005-10-13
EP1084261B1 (en) 2004-09-08
AR020080A1 (es) 2002-04-10
EP1084261A1 (en) 2001-03-21
CA2329133C (en) 2011-07-12
PT1084261E (pt) 2005-01-31
US6936257B1 (en) 2005-08-30
USRE41745E1 (en) 2010-09-21
DE69920011T2 (de) 2005-09-15
GB2337755A (en) 1999-12-01
WO1999063098A1 (en) 1999-12-09
GB2337755B (en) 2003-10-29
ES2224655T3 (es) 2005-03-01
BR9910814A (pt) 2001-02-13
ATE275631T1 (de) 2004-09-15
DE69920011D1 (de) 2004-10-14
EP1084261B8 (en) 2004-12-15
AU3834999A (en) 1999-12-20
CA2329133A1 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
DK1084261T3 (da) Rekombinant vaccine mod venezuelansk hesteencephalitis
NO20004758L (no) Vaksinesammensetning
NO20003302D0 (no) Vaksine
DE60025890D1 (de) Verbesserter Druckkopf
DE69933647D1 (de) Rekombinante lysophosphatidsäure - phosphatase.
DE60043733D1 (de) Paketauthentifizierung
NO20003934L (no) Oksydkatalysatorer
DE60037189D1 (de) Rekombinante, natrium-jodid symporter-kodierende adenoviren
NO20005599L (no) Vaksine
DK1180041T4 (da) Vaccine mod ISA-virus
IT247655Y1 (it) Protettore labiale.
DE59904378D1 (de) Umlenkeinrichtung
NO20013933D0 (no) Peptider
DK1105498T3 (da) HIV vaccine
ES1036791Y (es) Modulo contenedor-botellero perfeccionado.
IT1292534B1 (it) Procedimento per preparare e confezionare wuerstel.
ES1037044Y (es) Sobre perfeccionado.
ES1037494Y (es) Sobre perfeccionado.
ES1034808Y (es) Sobre de envio perfeccionado.
ITMI981384A0 (it) Vaccino per hiv
ES1032362Y (es) Sobre perfeccionado.
ES1039493Y (es) Vaso perfeccionado.
ES1042024Y (es) Sobre perfeccionado.
ITBO980581A0 (it) Siringa odontoiatrica .
ES1038368Y (es) Sobre reutilizable perfeccionado.